These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24164004)

  • 1. Poor risk assessment limits breast cancer survival.
    Reinke T
    Manag Care; 2013 Sep; 22(9):6-7. PubMed ID: 24164004
    [No Abstract]   [Full Text] [Related]  

  • 2. Skipping chemo. A lot of breast-cancer survivors are doing it, not always for good reasons.
    Gupta S
    Time; 2003 Feb; 161(5):68. PubMed ID: 12608103
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of 70-gene MammaPrint signature in node-negative breast cancer.
    Chen E; Tong KB; Malin JL
    Am J Manag Care; 2010 Dec; 16(12):e333-42. PubMed ID: 21291290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keeping breast cancer at bay. Women at risk are asked to weigh the pros and cons of a prevention pill.
    Brink S
    US News World Rep; 1999 May; 126(21):76. PubMed ID: 10387894
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy.
    Skinner CS; Rawl SM; Moser BK; Buchanan AH; Scott LL; Champion VL; Schildkraut JM; Parmigiani G; Clark S; Lobach DF; Bastian LA
    J Gen Intern Med; 2005 Apr; 20(4):360-5. PubMed ID: 15857495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
    Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
    J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting adjuvant chemotherapy: a good idea that needs to be proven!
    Hayes DF
    J Clin Oncol; 2012 Apr; 30(12):1264-7. PubMed ID: 22355050
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality of life varies for breast cancer survivors.
    Health News; 2002 Mar; 8(3):7. PubMed ID: 11910850
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer prevention: patient decision making and risk communication in the high risk setting.
    Ozanne EM; Wittenberg E; Garber JE; Weeks JC
    Breast J; 2010; 16(1):38-47. PubMed ID: 19889168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. God at the bedside.
    Groopman J
    N Engl J Med; 2004 Mar; 350(12):1176-8. PubMed ID: 15028822
    [No Abstract]   [Full Text] [Related]  

  • 12. Intraductal therapy for the prevention of breast cancer.
    Jacobs L; Sukumar S; Stearns V
    Curr Opin Investig Drugs; 2010 Jun; 11(6):646-52. PubMed ID: 20496259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?
    Hillner BE; Smith TJ
    J Clin Oncol; 2007 Feb; 25(6):611-3. PubMed ID: 17308264
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary breast cancer: some considerations concerning its management.
    Fisher B
    Surg Annu; 1971; 3(0):227-48. PubMed ID: 4367373
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant therapies for very young women with early stage breast cancer.
    Freedman RA; Partridge AH
    Breast; 2011 Oct; 20 Suppl 3():S146-9. PubMed ID: 22015283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conceptualizing risk.
    CMAJ; 1999 Jun; 160(13):1809-11. PubMed ID: 10405657
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary care concerns in breast cancer patients.
    Fenton MA
    Med Health R I; 2010 Oct; 93(10):304-7. PubMed ID: 21284269
    [No Abstract]   [Full Text] [Related]  

  • 18. Personalizing cardiovascular disease prevention among breast cancer survivors.
    Singla A; Kumar G; Bardia A
    Curr Opin Cardiol; 2012 Sep; 27(5):515-24. PubMed ID: 22874128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exquisite sensitivity of TP53 mutant breast cancers to dose-dense chemotherapy].
    Lehmann-Che J; Turpin E; Bertheau P; Espié M; de Thé H
    Med Sci (Paris); 2007 Nov; 23(11):1021-3. PubMed ID: 18021719
    [No Abstract]   [Full Text] [Related]  

  • 20. Mammography surveillance and mortality in older breast cancer survivors.
    Lash TL; Fox MP; Buist DS; Wei F; Field TS; Frost FJ; Geiger AM; Quinn VP; Yood MU; Silliman RA
    J Clin Oncol; 2007 Jul; 25(21):3001-6. PubMed ID: 17548838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.